Selected article for: "acute infection and immune system"
Author: Li, Juan; Liu, Hong-Hui; Yin, Xiao-Dong; Li, Cheng-Cheng; Wang, Jing
Title: COVID-19 illness and autoimmune diseases: recent insights
  • Cord-id: 1g96r99n
  • Document date: 2021_2_28
    • ID: 1g96r99n
    Snippet: BACKGROUND: The aim of this review is to explore whether patients with autoimmune diseases (AIDs) were at high risk of infection during the COVID-19 epidemic and how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic affected immune system. METHODS: A systematic literature search was performed using the foreign databases (NCBI, web of science, EBSCO, ELSEVIER ScienceDirect) and Chinese databases (WanFang, CNKI (China National Knowledge Infrastructure), VIP, CBM) to locate all
    Document: BACKGROUND: The aim of this review is to explore whether patients with autoimmune diseases (AIDs) were at high risk of infection during the COVID-19 epidemic and how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic affected immune system. METHODS: A systematic literature search was performed using the foreign databases (NCBI, web of science, EBSCO, ELSEVIER ScienceDirect) and Chinese databases (WanFang, CNKI (China National Knowledge Infrastructure), VIP, CBM) to locate all relevant publications (up to January 10, 2021). The search strategies used Medical Search Headings (MeSH) headings and keywords for “COVID-19” or “SARS-CoV-2” or “coronavirus” and “autoimmune disease”. RESULTS: This review evaluates the effect of SARS-CoV-2 on the immune system through ACE-2 receptor binding as the main pathway for cell attachment and invasion. It is speculated that SARS-COV-2 infection can activate lymphocytes and inflammatory response, which may play a role in the clinical onset of AIDs and also patients were treated with immunomodulatory drugs during COVID-19 outbreak. Preliminary studies suggested that the risk of developing severe forms of COVID-19 in patients with AIDs treated with immunomodulators or biologics might not increase. A large number of samples are needed for further verification, leading to an excessive immune response to external stimuli. CONCLUSION: The relationship between autoimmune diseases and SARS-CoV-2 infection is complex. During the COVID-19 epidemic, individualized interventions for AIDs should be provided such as Internet-based service.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and acute patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
    • abdominal pain and acute respiratory illness: 1, 2, 3, 4, 5, 6, 7, 8
    • abdominal pain and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • abdominal pain and adjunct therapy: 1, 2
    • abdominal pain and admission follow: 1
    • abdominal pain and lockdown impact: 1, 2, 3, 4
    • abdominal pain and lockdown impact evaluate: 1, 2
    • abdominal pain and long term treatment: 1, 2, 3, 4
    • abdominal pain and longitudinal study: 1, 2
    • abdominal pain and lung disease: 1, 2, 3, 4, 5, 6, 7
    • abdominal pain and lung inflammation: 1
    • abdominal pain and lung injury: 1, 2, 3, 4, 5
    • abdominal pain and lung tissue: 1, 2
    • abdominal pain and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • abdominal pain and lymphocyte ratio: 1, 2, 3, 4, 5
    • abdominal pain and lymphocyte ratio neutrophil: 1, 2, 3, 4, 5
    • abdominal pain and lymphocyte subset: 1
    • abdominal pain and macrophage activation: 1, 2, 3, 4
    • abdominal pain new onset diarrhea and acute respiratory syndrome: 1